Medicus Pharma (MDCX) Stock Price, News & Analysis

Company Overview

Medicus Pharma Ltd. is a life sciences company focused on the development, acquisition and commercialization of pharmaceutical and medical technologies. The company’s activities are centered primarily on specialty healthcare markets, including dermatology, wound care and medical aesthetics.

Medicus Pharma seeks to advance products and therapies intended to address underserved clinical needs and to expand access to innovative treatments. Its portfolio may include internally developed and acquired products, with commercialization efforts directed toward healthcare providers and patients in markets where the company has appropriate regulatory and distribution capabilities.

The company is based in Canada and trades on the Nasdaq Capital Market under the symbol MDCX. Publicly available information about its current product portfolio, geographic reach and leadership team is limited.

Key Stats

• Today's Range: $0.16 to $0.17
• 50-Day Range: $0.15 to $0.41
• 52-Week Range: $0.14 to $3.05
• Volume: 3.64 million shs
• Average Volume: 10.21 million shs
• Market Capitalization: $10.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.00
• Consensus Rating: Moderate Buy

Medicus Pharma Stock Analysis - MarketRank™

Medicus Pharma scored higher than 46% of companies evaluated by MarketBeat, and ranked 644th out of 898 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medicus Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 1 sell rating.

Upside Potential

Medicus Pharma has a consensus price target of $9.00, representing about 5,387.8% upside from its current price of $0.16.

Amount of Analyst Coverage

Medicus Pharma has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Medicus Pharma are expected to grow in the coming year, from ($0.73) to ($0.55) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medicus Pharma is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medicus Pharma is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.78% of the float of Medicus Pharma has been sold short.

Short Interest Ratio / Days to Cover

Medicus Pharma has a short interest ratio ("days to cover") of 2.59, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medicus Pharma has recently increased by 20.35%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Medicus Pharma does not currently pay a dividend.

Dividend Growth

Medicus Pharma does not have a long track record of dividend growth.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: -0.10

News Sentiment

Medicus Pharma has a news sentiment score of -0.10. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Medicus Pharma this week, compared to 5 articles on an average week.

Search Interest

15 people have searched for MDCX on MarketBeat in the last 30 days. This is an increase of 114% compared to the previous 30 days.

MarketBeat Follows

11 people have added Medicus Pharma to their MarketBeat watchlist in the last 30 days. This is an increase of 10% compared to the previous 30 days.

Company Ownership

• Score: 0.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medicus Pharma insiders have not sold or bought any company stock.

Percentage Held by Insiders

8.10% of the stock of Medicus Pharma is held by insiders.

Percentage Held by Institutions

Medicus Pharma has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/12/2026
• Today: 9/22/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:MDCX
• Previous Symbol: NASDAQ:MDCX
• CIK: 1997296
• Web: www.medicuspharma.com
• Phone: (610) 540-7515
• Fax: N/A
• Employees: 16
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Medicus Pharma: $9.00
• High Price Target: $9.00
• Low Price Target: $9.00
• Potential Upside/Downside: +5,387.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.46)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$35.46 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -3,137.84%
• Return on Assets: -263.24%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.57
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 63,180,000
• Free Float: 58,063,000
• Market Cap: $10.36 million
• Optionable: N/A
• Beta: 0.12